Help us: Donate
Follow us on:

Methylation Clocks that Measure the Biological Age of Cats

Image of a cat with a clockImage of a cat with a clock

Today, we have something a little bit different: progress in aging biomarkers but, this time, for cats!

The race has been on for some years now to create biomarkers that can accurately measure biological age. Having such biomarkers is critical in the development of therapies that target the aging processes directly, and one of the most promising ways to measure biological age are DNA methylation clocks.

These DNA methylation clocks measure the methylation status of key sites on the genome, which were chosen due to their relevance to aging, in order to give an estimate of biological age. The methylation status of these sites determines gene expression and predictably shift as we get older, making it possible to examine the genome and say with some certainty how old someone is.

These changes of methylation status are thought to be one of the reasons we age and are part of the aging process known as epigenetic alterations.

There are an ever-increasing number of these clocks being developed, and Dr. Steve Horvath, author of this new study, and his team have been very active in creating them. The unusual thing about this study is that these methylation clocks are not measuring the biological age of mice or humans; rather, they are for cats.

Human DNA methylation profiles have been used successfully to develop highly accurate biomarkers of aging (“epigenetic clocks”). Although these human epigenetic clocks are not immediately applicable to all species of the animal kingdom, the principles underpinning them appear to be conserved even in animals that are evolutionarily far removed from humans. This is exemplified by recent development of epigenetic clocks for mice and other mammalian species. Here, we describe epigenetic clocks for the domestic cat (Felis catus), based on methylation profiles of CpGs with flanking DNA sequences that are highly conserved between multiple mammalian species. Methylation levels of these CpGs are measured using a custom-designed Infinium array (HorvathMammalMethylChip40). From these, we present 3 epigenetic clocks for cats; of which, one applies only to blood samples from cats, while the remaining two dual-species human-cat clocks apply both to cats and humans. As the rate of human epigenetic ageing is associated with a host of health conditions and pathologies, it is expected that these epigenetic clocks for cats would do likewise and possess the potential to be further developed for monitoring feline health as well as being used for identifying and validating anti-aging interventions.


The development of methylation clocks for cats is important in the context of pet longevity research and the development of therapies that may allow our furry friends to live longer and healthier lives. Having access to accurate methylation clocks able to measure aging is critical to ascertain if a particular anti-aging drug or therapy has been successful, and that applies equally to cats and humans.

Some therapies might initially reach companion animals before moving to human trials, so this work is also important in that context. That said, the common practice for developing drugs for pets is to take something that’s already approved for humans and get it approved as a pet therapy. Either way, a cat methylation clock will be useful.

The bottom line here is that if we are going to develop ways to live longer and healthier lives as humans, then it makes sense to take our beloved pets with us on the journey, so this is a step in the right direction.

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. We are committed to responsible journalism, free from commercial or political influence, that allows you to make informed decisions about your future health.

All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future. You can support us by making a donation or in other ways at no cost to you.

Vital Muscle Enzyme Declines With Aging

Research published in Nature Metabolism has described PCYT2, an enzyme essential for muscle function, and how it declines with aging....

The Human Cost of Metabolic Diseases

A new paper published in Cell Metabolism has shown the growing influence of metabolic diseases in an aging population. Related...

Rep. Bilirakis on the Longevity Science Caucus

We in the longevity field have received powerful allies on Capitol Hill with the creation of the bipartisan Congressional Caucus...

Sleep Apnea and Inflammatory Biomarkers of Tooth Decay

A study published in Heliyon has explained a relationship between sleep apnea and an increase of inflammatory factors in the...

About the author

Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 600 articles on the topic, interviewed over 100 of the leading researchers in the field, hosted livestream events focused on aging, as well as attending various medical industry conferences. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, Swiss Monthly, Keep me Prime, and New Economy Magazine. Steve is one of three recipients of the 2020 H+ Innovator Award and shares this honour with Mirko Ranieri – Google AR and Dinorah Delfin – Immortalists Magazine. The H+ Innovator Award looks into our community and acknowledges ideas and projects that encourage social change, achieve scientific accomplishments, technological advances, philosophical and intellectual visions, author unique narratives, build fascinating artistic ventures, and develop products that bridge gaps and help us to achieve transhumanist goals. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project.
No Comments
Write a comment:


Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.